Genetic and clinical mosaicism in a patient with neurofibromatosis type 1

By Vandenbroucke Ina   Doorn Remco   Callens Tom   Cobben Jan   Starink Theo   Messiaen Ludwine  

Human Genetics, Vol. 114, Iss. 3, 2004-02 ,pp. : 284-290

Springer Publishing Company

Access to resources Recommend Favorite

Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1

By Ars Elisabet   Serra Eduard   García Judit   Kruyer Helena   Gaona Antonia   Lázaro Conxi   Estivill Xavier  

Human Molecular Genetics, Vol. 9, Iss. 2, 2000-01 ,pp. : 237-247

Oxford University Press

Access to resources Recommend Favorite

Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1 (NF1)

By Wittinghofer A.  

Human Molecular Genetics, Vol. 7, Iss. 8, 1998-08 ,pp. : 1261-1268

Oxford University Press

Access to resources Recommend Favorite

An Illustrative Case of Neurofibromatosis Type 1 and NF1 Microdeletion

By  

Molecular Syndromology, Vol. 1, Iss. 3, 2010-09 ,pp. : 133-135

Karger

Access to resources Recommend Favorite

Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1

By Sabbagh Audrey   Pasmant Eric   Laurendeau Ingrid   Parfait Batrice   Barbarot Sbastien   Guillot Bernard   Combemale Patrick   Ferkal Salah   Vidaud Michel   Aubourg Patrick   Vidaud Dominique   Wolkenstein Pierre  

Human Molecular Genetics, Vol. 18, Iss. 15, 2009-08 ,pp. : 2768-2778

Oxford University Press

Access to resources Recommend Favorite